219 related articles for article (PubMed ID: 1574031)
21. Plasma free metanephrines for diagnosis of neuroblastoma patients.
Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
[TBL] [Abstract][Full Text] [Related]
22. Reference intervals for urinary catecholamines and metabolites from birth to adulthood.
Pussard E; Neveux M; Guigueno N
Clin Biochem; 2009 Apr; 42(6):536-9. PubMed ID: 19027729
[TBL] [Abstract][Full Text] [Related]
23. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
Piöchl E; Käser H; Klein H
Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
[TBL] [Abstract][Full Text] [Related]
24. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
25. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases.
Gerlo EA; Sevens C
Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208
[TBL] [Abstract][Full Text] [Related]
26. Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards.
Muskiet FA; Thomasson CG; Gerding AM; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG
Clin Chem; 1979 Mar; 25(3):453-60. PubMed ID: 262188
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic neuroblastoma as a poor prognostic subgroup.
Nakagawara A; Ikeda K; Tasaka H
J Pediatr Surg; 1988 Apr; 23(4):346-9. PubMed ID: 3385588
[TBL] [Abstract][Full Text] [Related]
28. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
29. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
30. [Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms].
Käser H
Helv Paediatr Acta; 1972; 29():Suppl 29:1-114. PubMed ID: 4661091
[No Abstract] [Full Text] [Related]
31. Suppression of norepinephrine secretion by dopamine in children with neuroblastoma: evidence for precursor inhibition in catecholamine pathway.
Sato T; Minami S; Igarashi N; Miyagawa K
Endocrinol Jpn; 1989 Aug; 36(4):595-603. PubMed ID: 2583066
[TBL] [Abstract][Full Text] [Related]
32. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
Barco S; Gennai I; Reggiardo G; Galleni B; Barbagallo L; Maffia A; Viscardi E; De Leonardis F; Cecinati V; Sorrentino S; Garaventa A; Conte M; Cangemi G
Clin Biochem; 2014 Jun; 47(9):848-52. PubMed ID: 24769278
[TBL] [Abstract][Full Text] [Related]
33. Effect of diet on urinary excretion of VMA, HVA, metanephrine, and total free catecholamine in normal preschool children.
Weetman RM; Rider PS; Oei TO; Hempel JS; Baehner RL
J Pediatr; 1976 Jan; 88(1):46-50. PubMed ID: 1245941
[TBL] [Abstract][Full Text] [Related]
34. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
Miano L; Kolloch R; De Quattro V
Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220
[TBL] [Abstract][Full Text] [Related]
35. [Urinary excretion of the catecholamines adrenaline, noradrenaline and dopamine as well as the derivatives metanephrine and normetanephrine in heart disease patients].
Mäurer W; Yoshida Y; Kübler W
Z Kardiol; 1976 Dec; 65(12):1124-38. PubMed ID: 1014804
[TBL] [Abstract][Full Text] [Related]
36. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
[TBL] [Abstract][Full Text] [Related]
37. A case of new dysautonomia-like disorder found in Japan. I. Clinical and metabolic studies.
Suzuki T; Higa S; Hayashi A; Nakagawa T; Fujii K
Eur Neurol; 1976; 14(2):146-60. PubMed ID: 1248495
[TBL] [Abstract][Full Text] [Related]
38. Quantification of urinary catecholamines, their abundant metabolites, and 5-hydroxyindoleacetic acid by high performance liquid chromatography and electrochemical detection, using a single mobile phase and uniform isocratic conditions.
Radjaipour M; Raster H; Liebich HM
Eur J Clin Chem Clin Biochem; 1994 Aug; 32(8):609-13. PubMed ID: 7529572
[TBL] [Abstract][Full Text] [Related]
39. Catecholamine metabolism during heroin use.
Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
[TBL] [Abstract][Full Text] [Related]
40. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
